Letter: non‐invasive prediction models to exclude cirrhosis in <scp>NAFLD</scp> —not everyone fits the mould. Authors' reply-Reference-Cited by-同舟云学术

Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD —not everyone fits the mould. Authors' reply

Published:2022-06-10 Issue:1 Volume:56 Page:182-183
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Brandman Danielle¹^ORCID,Boyle Marie²,McPherson Stuart²^ORCID,Van Natta Mark L.³,Sanyal Arun J.⁴^ORCID,Kowdley Kris⁵,Neuschwander‐Tetri Brent⁶,Chalasani Naga⁷^ORCID,Abdelmalek Manal F.⁸,Terrault Norah A.⁹^ORCID,McCullough Art¹⁰,Bettencourt Ricki¹¹,Caussy Cyrielle¹¹^ORCID,Kleiner David E.¹²,Behling Cynthia¹³,Tonascia James³,Anstee Quentin M.²^ORCID,Loomba Rohit¹¹^ORCID

Affiliation:

1. Division of Gastroenterology, Department of Medicine University of California San Francisco San Francisco California USA

2. Translational & Clinical Research Institute, Faculty of Medical Sciences Newcastle University, Newcastle upon Tyne, UK & Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust Newcastle upon Tyne UK

3. John Hopkins Bloomberg School of Public Health Baltimore Maryland USA

4. Department of Internal Medicine Medical College of Virginia Richmond Virginia USA

5. Swedish Medical Group Seattle Washington USA

6. Division of Gastroenterology and Hepatology, Department of Medicine Saint Louis University Saint Louis Missouri USA

7. Division of Gastroenterology and Hepatology, Department of Medicine Indiana University Indianapolis Indiana USA

8. Division of Gastroenterology, Hepatology, and Nutrition Duke University Durham North Carolina USA

9. Division of Gastroenterology and Liver, Keck Medicine University of Southern California Los Angeles California USA

10. Department of Gastroenterology and Hepatology Cleveland Clinic Cleveland Ohio USA

11. NAFLD Research Center, Department of Medicine University of California San Diego San Diego California USA

12. Laboratory of Pathology, National Cancer Institute National Institutes of Health Bethesda Maryland USA

13. Analytic Pathology Medical Group Sharp Memorial Hospital San Diego California USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16972

Reference8 articles.

1. Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD – not everyone fits the mould

2. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease ( NAFLD )

3. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

4. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease